189 related articles for article (PubMed ID: 18849877)
1. Chemotherapy-related amenorrhea in premenopausal women with breast cancer.
Lee S; Kil WJ; Chun M; Jung YS; Kang SY; Kang SH; Oh YT
Menopause; 2009; 16(1):98-103. PubMed ID: 18849877
[TBL] [Abstract][Full Text] [Related]
2. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
[TBL] [Abstract][Full Text] [Related]
4. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
Tham YL; Sexton K; Weiss H; Elledge R; Friedman LC; Kramer R
Am J Clin Oncol; 2007 Apr; 30(2):126-32. PubMed ID: 17414460
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for premenopausal patients with early breast cancer.
Kurebayashi J
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):51-4. PubMed ID: 18197006
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Vehmanen L; Elomaa I; Blomqvist C; Saarto T
J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
[No Abstract] [Full Text] [Related]
9. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
Partridge A; Gelber S; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Winer E
Eur J Cancer; 2007 Jul; 43(11):1646-53. PubMed ID: 17512721
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
Asaga S; Ando J; Arai T; Fujii H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
[TBL] [Abstract][Full Text] [Related]
11. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival.
Collichio F; Pandya K
Oncology (Williston Park); 1994 Dec; 8(12):45-52. PubMed ID: 7888312
[TBL] [Abstract][Full Text] [Related]
12. Ovarian function and childbearing issues in breast cancer survivors.
Gadducci A; Cosio S; Genazzani AR
Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
[TBL] [Abstract][Full Text] [Related]
13. Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients.
Kil WJ; Ahn SD; Shin SS; Lee SW; Choi EK; Kim JH; Son BH; Ahn SH; Kim WK; Kim SB
Breast Cancer Res Treat; 2006 Apr; 96(3):245-50. PubMed ID: 16555128
[TBL] [Abstract][Full Text] [Related]
14. Fertility and adjuvant treatment in young women with breast cancer.
Partridge AH; Ruddy KJ
Breast; 2007 Dec; 16 Suppl 2():S175-81. PubMed ID: 17804236
[TBL] [Abstract][Full Text] [Related]
15. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
Fornier MN; Modi S; Panageas KS; Norton L; Hudis C
Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.
Zekri JM; El-Helw LM; Purohit OP; Hatton MQ; Coleman RE
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):513-6. PubMed ID: 18513930
[TBL] [Abstract][Full Text] [Related]
17. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
Wolff AC; Davidson NE
J Clin Oncol; 2006 Nov; 24(31):4949-51. PubMed ID: 17075110
[No Abstract] [Full Text] [Related]
18. Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.
Briest S; Wolff AC
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1243-53. PubMed ID: 17892424
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.
Anders C; Marcom PK; Peterson B; Gu L; Unruhe S; Welch R; Lyons P; Behera M; Copland S; Kimmick G; Shaw H; Snyder S; Antenos M; Woodruff T; Blackwell K
Cancer Invest; 2008; 26(3):286-95. PubMed ID: 18317970
[TBL] [Abstract][Full Text] [Related]
20. Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
Rossi E; Morabito A; De Maio E; Di Rella F; Esposito G; Gravina A; Labonia V; Landi G; Nuzzo F; Pacilio C; Piccirillo MC; D'Aiuto G; D'Aiuto M; Rinaldo M; Botti G; Gallo C; Perrone F; de Matteis A
J Clin Oncol; 2008 Jan; 26(2):264-70. PubMed ID: 18086795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
